| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40477fe7aca8fc32e4e85dd06baafe3a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 |
| filingDate |
2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_861f96a1301188292381a57debed9330
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e6437c8dcd5e8778476e3351213b45f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c505bfb0cf35e7fa4bdb555df0ee94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aff14370bd6f95dda212485e856df4df |
| publicationDate |
2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2617968-C2 |
| titleOfInvention |
Adapted recombinase for asymmetric target site recombination in a variety of retroviruses strains |
| abstract |
FIELD: biotechnology. n SUBSTANCE: inventions relate to a method for preparation of an expression vector encoding an adapted recombinase capable of asymmetric target sequences recombination within the long terminal repeat (LTR) of the multiple HIV-1 strains proviral DNA built into the host cell genome, as well as the resulting expression vector, cells transfected by this vector, the expressed recombinase and a pharmaceutical composition comprising an expression vector, cell and/or recombinase. n EFFECT: possible use for treatment or prevention of HIV-1 infection in a subject. n 28 cl, 5 dwg, 2 ex |
| priorityDate |
2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |